癌症的靶向紫杉烷疗法。 - Suppr

Suppr

超能文献

Targeted taxane therapy for cancer.

作者信息

Whelan Jo

出版信息

Drug Discov Today. 2002 Jan 15;7(2):90-2. doi: 10.1016/s1359-6446(01)02149-3.

DOI:10.1016/s1359-6446(01)02149-3

PMID:11790612

Abstract

摘要

相似文献

Targeted taxane therapy for cancer.癌症的靶向紫杉烷疗法。

Drug Discov Today. 2002 Jan 15;7(2):90-2. doi: 10.1016/s1359-6446(01)02149-3.

Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.紫杉烷脂质体对无胸腺裸鼠人卵巢肿瘤异种移植瘤的抗肿瘤疗效。

J Pharm Sci. 1995 Dec;84(12):1400-4. doi: 10.1002/jps.2600841204.

Improved chemical strategies for the targeted therapy of cancer.

Angew Chem Int Ed Engl. 2003 Oct 13;42(39):4726-8. doi: 10.1002/anie.200301666.

Preclinical evaluation of new taxoids.新型紫杉烷类化合物的临床前评估

Curr Pharm Des. 2001 Sep;7(13):1251-7. doi: 10.2174/1381612013397465.

[A Case of Taxane-Pretreated Metastatic Gastric Cancer with Excellent Response to Nab-Paclitaxel].[一例对多西他赛预处理的转移性胃癌患者使用白蛋白结合型紫杉醇疗效显著的病例]

Gan To Kagaku Ryoho. 2015 Nov;42(12):2088-90.

Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.紫杉烷类药物在乳腺癌辅助治疗和新辅助治疗中的新作用：潜力与问题

Surg Clin North Am. 2003 Aug;83(4):943-71. doi: 10.1016/S0039-6109(03)00071-9.

Optimizing taxane use in MBC in the emerging era of targeted chemotherapy.优化靶向化疗时代MBC 中紫杉烷类药物的应用。

Crit Rev Oncol Hematol. 2013 Mar;85(3):315-31. doi: 10.1016/j.critrevonc.2012.09.009. Epub 2012 Oct 30.

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC.随机 III 期 PITCAP 试验和荟萃分析显示，局部晚期 NSCLC 患者在诱导化疗后行胸部放疗联合或不联合紫杉醇类药物化疗的效果。

Lung Cancer. 2016 Oct;100:30-37. doi: 10.1016/j.lungcan.2016.07.026. Epub 2016 Jul 27.

[Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].[作用于微管的抗癌药物——长春瑞滨、紫杉醇和多西他赛治疗肺癌的近期结果]

Gan To Kagaku Ryoho. 1992 Nov;19(13):2150-6.

Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.聚谷氨酸紫杉醇（XYOTAX，CT-2103）：一种大分子紫杉烷。

J Control Release. 2005 Dec 5;109(1-3):120-6. doi: 10.1016/j.jconrel.2005.09.033. Epub 2005 Nov 16.

引用本文的文献

Anti-Proliferative Activity of Triterpenes Isolated from Clinicanthus nutans on Hep-G2 Liver Cancer Cells.从风车草中分离得到的三萜类化合物对肝癌细胞Hep-G2的抗增殖活性

Asian Pac J Cancer Prev. 2019 Feb 26;20(2):563-567. doi: 10.31557/APJCP.2019.20.2.563.

The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.布鲁顿酪氨酸激酶抑制剂依鲁替尼（PCI-32765）克服ABCB1和ABCC10过表达细胞及肿瘤中的紫杉醇耐药性。

Mol Cancer Ther. 2017 Jun;16(6):1021-1030. doi: 10.1158/1535-7163.MCT-16-0511. Epub 2017 Mar 6.

Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.用于胰腺癌分子成像和靶向治疗的荧光抗体-药物偶联物的研发与评估

PLoS One. 2016 Jun 23;11(6):e0157762. doi: 10.1371/journal.pone.0157762. eCollection 2016.

Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.马西替尼拮抗ATP结合盒亚家族C成员10介导的紫杉醇耐药性：一项临床前研究。

Mol Cancer Ther. 2014 Mar;13(3):714-23. doi: 10.1158/1535-7163.MCT-13-0743. Epub 2014 Jan 15.

Tumor-targeting drug delivery of new-generation taxoids.新一代紫杉烷类的肿瘤靶向药物递送。

Future Med Chem. 2012 Jan;4(1):33-50. doi: 10.4155/fmc.11.167.

Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.癌症化疗和器官移植中使用的非抗真菌药物对念珠菌属和曲霉属物种的发育和毒力的直接影响。

Virulence. 2011 Jul-Aug;2(4):280-95. doi: 10.4161/viru.2.4.16764. Epub 2011 Jul 1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验